At last, the Food and Drug Administration (FDA) is saying what its European counterparts have been saying for the past two years. On October 13, the FDA issued the following press release:
FDA: Possible increased risk of thigh bone fracture with bisphosphonates
Labeling change adds warning about possible risks of long-term use of osteoporosis drugs
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm229171.htm
All we can say in the Femur Friends support group (over 50 members, including one man) is, "About time!"
Last May, some of our members met with FDA officials to voice our concerns. Looks like we made our point. Just for the record, we do not think that femur fractures are all that rare. Some thigh-bone (femur) fractures are erroneously classified as hip fractures, which they are not.
I saw this on the news and immediately thought of you. What gets me is that at the end of the newscast they said that doctors are recommending you keep taking it. What's up with that!
ReplyDeleteSheez. Google "fosamax femur fracture" and you can make that judgment yourself. Like Val, I thought of you when I saw the news. About time.
ReplyDeleteVal, I don't know why they say in one breath that a person is at higher risk for femur fractures if he or she takes the drug for too many years and then in the next breath tell folks not to stop. All I know is, I no longer take Fosamax or its generic. I am counting on calcium and higher doses of Vitamin D to do the trick.
ReplyDeleteI didn't see this on the news, but glad to hear it. You and your group must feel really good! you all made an impact.
ReplyDelete